Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018, Public Library of Science
N. brasiliensis L3 fed with APC labelled RBC (anti-Ter119). Picture shows specific uptake of RBC into the larval intestine, and the accompanying dark pigment formation. Credit: Tiffany Bouchery

In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens by Tiffany Bouchery of Malaghan Institute of Medical Research, New Zealand, and colleagues could help pave the way to new treatments against hookworms in humans.

Hookworms are parasitic worms that infect hundreds of millions of people worldwide, primarily in developing countries. Transmitted through the skin via contaminated soil, they take up residence in the intestines, where they feed on blood and cause anemia, stunted childhood development, and complications during pregnancy.

New treatments are needed to combat hookworms, and one potential strategy is to target their blood-feeding activity. From their host's blood, hookworms scavenge a molecule called heme—a molecular component of hemoglobin, which transports oxygen in the blood. Heme is toxic on its own, and many blood-feeding parasites have developed heme-detoxification mechanisms; Bouchery and colleagues hypothesized that hookworms may use a similar strategy.

The researchers performed a series of experiments using a mouse-infecting hookworm species. First, they showed that it behaves similarly to its human-infecting counterparts, feeding on blood and causing anemia in mice. Next, they found that feeding or haemoglobin to the hookworm fosters its growth and causes it to produce a dark brown pigment similar to hemozoin, the detoxified form of heme produced by many other -feeding parasites.

The scientists then tested the effects of quinolones, chemical compounds that are known to disrupt hemozoin formation in malaria and schistosoma parasites. They found that quinolones likewise disrupted production of the hemozoin-like pigment in mouse-infecting hookworms, interrupting their development and their ability to reproduce. Mice treated with quinolones had significantly lower levels of hookworms, eggs, and anemia.

Due to widespread drug resistance, quinolones are not a realistic weapon against human-infecting hookworms. However, these new findings suggest that development of other drugs or vaccines targeting heme-detoxification pathways could hold promise against human-infecting hookworms. The authors hope that "this leads to new opportunities to treat this most devastating of tropical diseases."

Explore further: Fast test can monitor drug resistance in hookworms

More information: Bouchery T, Filbey K, Shepherd A, Chandler J, Patel D, Schmidt A, et al. (2018) A novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development. PLoS Pathog 14(3): e1006931.

Related Stories

Fast test can monitor drug resistance in hookworms

December 8, 2016
More than 2 billion people around the world are infected with intestinal helminths, parasitic worms that can cause disease, complicate pregnancies, and stunt the growth of children. A number of drugs are currently used to ...

Sequencing the hookworm: Ancylostoma ceylanicum genome provides potential new drug, vaccine targets

March 2, 2015
In an advance that may potentially lead to new treatments for parasitic hookworms, scientists at the University of Massachusetts Medical School and Cornell University have sequenced the genome of the hookworm, Ancylostoma ...

Asthmatics could breathe easier in the future with help from an unlikely quarter—parasitic hookworms

October 26, 2016
Asthmatics could breathe easier in the future with help from an unlikely quarter—parasitic hookworms.

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.